Clinical Consults in Severe Asthma: New Approaches to Targeted Therapy

integritas

This series is provided by Integritas Communications.

This series is supported by an educational grant from AstraZeneca Pharmaceuticals.

Program Overview

As management options for the treatment of severe asthma continue to expand with the addition of effective biologic therapies, physicians often consult colleagues for advice on complex cases or challenging issues. This 3-episode Phone-a-Friend series features 3 expert physicians asking and answering questions related to the management of severe asthma. The series will cover a variety of topics, including patient symptom assessment; disease phenotyping; rationale for treatment escalation or switching; threshold for specialty referral and biologic initiation; biologic agent selection, safety, and monitoring; comanagement of common comorbid disease; and barriers/disparities in asthma care. Each episode is centered around a specific patient case.

Target Audience

The educational design of this activity addresses the needs of allergy/clinical immunology and pulmonology clinicians involved in the management of patients with severe asthma.

Modules

Module 1

A Primary Care Patient With Uncontrolled Asthma

Faculty Njira Lucia Lugogo, MD, MS; Neil Skolnik, MD

Credits Maximum of 0.5 AMA PRA Category 1 Credit

Expiration2024-06-26

Module 2

A Patient With Severe Asthma in Need of Additional Control

Faculty Flavia Hoyte, MD; Njira Lucia Lugogo, MD, MS

Credits Maximum of 0.5 AMA PRA Category 1 Credit

Expiration2024-08-18

Module 3

Managing the Patient With Severe Asthma and Common Comorbidities

Faculty Flavia Hoyte, MD; Njira Lucia Lugogo, MD, MS

Credits Maximum of 0.5 AMA PRA Category 1 Credit

Expiration2024-08-28